Related Experiment Video
Updated: Aug 9, 2026
11:14
Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
Hepatitis B virus genetic diversity
José M Echevarría1, Ana Avellón
1Service of Diagnostic Microbiology, National Centre of Microbiology, Instituto de Salud Carlos III, Madrid, Spain. jmecheva@isciii.es
Journal of Medical Virology
|April 20, 2006
Summary
Hepatitis B virus (HBV) variants with mutations in the surface antigen (HBsAg) can evade diagnostic tests and treatments. Understanding these HBV variants is crucial for managing infection and developing effective therapies.
Area of Science:
- Virology
- Genetics
- Immunology
Background:
- Hepatitis B virus (HBV) exhibits a high mutation rate due to its replication strategy involving reverse transcription.
- HBV is classified into genotypes and subtypes based on genomic and antigenic properties, with geographical distributions reflecting human population movements.
- Viral variants, particularly pre-core (pre-C) defective variants and those with mutations in the reverse-transcriptase (RT) region, impact treatment efficacy.
Purpose of the Study:
- To investigate the emergence and implications of Hepatitis B virus (HBV) variants.
- To understand the medical and public health relevance of HBV variants, including those affecting treatment resistance and diagnostic detectability.
Main Methods:
- Genomic sequencing for HBV genotype and subgenotype classification.
- Analysis of antigenic properties of HBV surface antigen (HBsAg) for subtype identification.
- Monitoring of viral populations for mutations associated with drug resistance and immune evasion.
Main Results:
- HBV variants with altered HBsAg are common in chronic carriers and can arise from mutation and selection pressures.
- Drug-resistant HBV variants can indirectly lead to the selection of HBsAg variants due to overlapping genomic regions.
- Some HBsAg variants are associated with reduced susceptibility to interferon and other antiviral treatments, as well as vaccine and immunotherapy resistance.
Conclusions:
- Emergence of specific HBV variants poses challenges for diagnosis, treatment, and prevention strategies.
- HBsAg variants can escape detection by diagnostic assays, impacting screening and carrier identification.
- Further research into HBV variant evolution is essential for improving clinical management and public health interventions.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
00:57Viral Recombination
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
00:36Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
01:26Size and Structure of Viral Genomes
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
01:29Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...